Skip to Content

School of Medicine Greenville

Dreskin Distinguished Endowed Lecture Series

E. Arthur Dreskin, M.D., had a long and distinguished career in medicine and public service until his death in 2006. In memory of his outstanding leadership in South Carolina, his family has established the Dr. E. Arthur Dreskin Distinguished Lecture Series. The endowed lecture series brings nationally and internationally prominent speakers to address and consult with our school’s community on topics of high importance to health care and leadership. The lecture is presented annually.

Learn more about Dr. E. Arthur Dreskin.


Past Lectures

2016 - Ian Crozier, M.D.

Ian Crozier, M.D., gave a comelling presentation about his experiences as both a physician for ebola patients and an ebola survior himself. 

About Dr. Ian Crozier

Dr. Ian CrozierDr. Ian Crozier is a Vanderbilt-trained infectious diseases specialist originally from Bulawayo, Zimbabwe. Over the past six years, primarily at the Infectious Diseases Institute (Kampala, Uganda), his work has focused on developing clinical reasoning skills in African clinicians providing complex care at African bedsides.

In August 2014, he was deployed by the World Health Organization (WHO) to the Kenema Government Hospital Ebola Treatment Unit in eastern Sierra Leone, a ground-zero setting for the Sierra Leone outbreak. After becoming infected, he was evacuated to Emory University Hospital, becoming critically ill, but emerging after a six-week hospitalization. Two months after clearing the virus from his blood he developed sight-threatening ocular inflammation with high amounts of viable Ebola virus detected in the eye, this in addition to a long list of other post-Ebola virus disease sequelae. He has been called one of the sickest Ebola survivors ever, and provides a unique perspective from a dual citizenship as Ebola doctor and Ebola survivor.

Currently, he serves a three-country technical role at WHO, focused on characterizing and understanding the sequelae of Ebola virus disease in West African survivors, targeting their clinical care needs, the management of residual risk and the scientific questions newly emerging at survivors’ bedsides.

2014 - Stephen Dreskin, M.D., Ph.D.

Stephen Dreskin, M.D., Ph.D., was the inaugural speaker for the Dreskin Distinguished Lectureship at the USC School of Medicine Greenville.

Dr. Dreskin’s lecture addressed food allergies, their epidemiology and immune system pathophysiology as well as current approaches to diagnosis and management.


About Stephen Dreskin, M.D., Ph.D

Stephen C. Dreskin, M.D., Ph.D.Stephen C. Dreskin, M.D., Ph.D. is a professor of Medicine and Immunology at the University of Colorado School of Medicine-Denver and medical director of the University of Colorado Allergy, Asthma, and Immunology Practice at the University of Colorado School of Medicine-Denver.

In addition, he is active in many national organizations. Currently, he is the chair of the Practice, Diagnostics, and Therapeutics (PDT) Committee of the American Academy of Allergy, Asthma and Immunology (AAAAI) and chair of the Plenary Workgroup for the 2016 AAAAI annual meeting. He also serves on the board of directors of the American Board of Allergy and Clinical Immunology.

Dr. Dreskin grew up in Greenville, South Carolina, earned a B.A. degree from the University of Pennsylvania and received his M.D. and Ph.D. degrees from Emory University. This was followed by a residency in Internal Medicine at the University of California Davis, Sacramento Medical Center and a fellowship in Allergy and Clinical Immunology at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

His primary research interest is the study of functional IgE-allergen interactions as they pertain to food allergies. In work funded by the National Institutes of Health and other sources, his laboratory has established that 2 small allergens, Ara h 2 and Ara h 6 are the major peanut allergens. Current efforts are directed at how these proteins cross-link IgE on mast cells to initiate the allergic response.

Dr. Dreskin’s primary clinical interest is the treatment of chronic urticaria and angioedema. He has written numerous clinical reviews on this topic and is the current author of the chapter on Chronic Urticaria and Angioedema for Goldman’s Cecil Medicine Textbook (24th ed).